87409-9
Ustekinumab Ab [Units/volume] in Serum or Plasma by Immunoassay
Active
Term Description
This term was created for, but not limited in use to, the submitter's Theradiag Lisa-Tracker Ustekinumab and anti-Ustekinumab test kits.
Part Descriptions
LP250851-5 Ustekinumab
Ustekinumab (UST) is a human immunoglobulin G1κ (IgG1κ) that binds sub-unit p40 of interleukin-12 (IL-12) and interleukin-23 (IL-23). IL-12 and IL-23 are parts of the Th1 and Th17 inflammatory pathways, respectively, and are important in the development of psoriasis. Psoriasis has pathogenic similarities to psoriatic arthritis (PsA) which is an inflammatory disorder that is often unresponsive to tumor necrosis factor (TNF) inhibitor therapy. Also, many patients with PsA who initially respond well to TNF inhibitors eventually stop responding. UST is not a TNF inhibitor and offers patients with PsA an alternative treatment which has been proven to be effective and safe for short-term use. The safety for long-term use of UST still needs further study. PMID: 24101949
Source: Regenstrief LOINC
LP250854-9 Ustekinumab Ab
Antibodies to ustekinumab (ATU) have been detected in 6.5% of patients who were receiving ustekinumab for13 months. The presence of ATU is associated with reduced levels of ustekinumab and treatment failure. The number of patients who develop ATU is similar to the number of patients who failed therapy with adalimumab regardless of whether those patients were positive or negative for antibodies to adalimumab. PMID: 26566272
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Ustekinumab Ab
- Property
- ACnc
- Time
- Pt
- System
- Ser/Plas
- Scale
- Qn
- Method
- IA
Additional Names
- Long Common Name
- Ustekinumab Ab [Units/volume] in Serum or Plasma by Immunoassay
- Short Name
- Ustekinumab Ab SerPl IA-aCnc
- Display Name
- Ustekinumab Ab IA Qn
- Consumer Name Alpha Get Info
- Ustekinumab antibody, Blood
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.63
- Last Updated
- Version 2.73 (MIN)
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 6769
Member of these Panels
LOINC | Long Common Name |
---|---|
101144-4 | Ustekinumab and Ustekinumab Ab panel - Serum or Plasma |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
el-GR | Greek (Greece) | Ουστεκινουμάμπη Αντίσωμα: Synonyms: ACnc Ουστεκινουμάμπη |
es-ES | Spanish (Spain) | Ustekinumab Anticuerpos: Synonyms: Cuantitativo |
es-MX | Spanish (Mexico) | Ustekinumab Ab: |
fr-FR | French (France) | Ustekinumab anticorps: |
it-IT | Italian (Italy) | Ustekinumab Ab: Synonyms: anticorpo Concentrazione Arbitraria Immunoassay Livelli farmacologici e tossicologia Plasma Punto nel tempo (episodio) Siero Siero o Plasma |
nl-NL | Dutch (Netherlands) | ustekinumab As: Synonyms: antistof; |
zh-CN | Chinese (China) | 优特克单抗 抗体: Synonyms: Ab; |
Example Units
Unit | Source |
---|---|
[arb'U]/mL | Example UCUM Units |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=87409-9
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://